Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jan Ole Werner"'
Autor:
Annika Nelde, Daniel J. Kowalewski, Linus Backert, Heiko Schuster, Jan-Ole Werner, Reinhild Klein, Oliver Kohlbacher, Lothar Kanz, Helmut R. Salih, Hans-Georg Rammensee, Stefan Stevanović, Juliane S. Walz
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Recent studies suggest that CLL is an immunogenic disease, which might be effectively targeted by antigen-specific T-cell-based immunotherapy. However, CLL is associated with a profound immune defect, which might represent a critical limitation for m
Externí odkaz:
https://doaj.org/article/15df9cff2f754b7fa0d8ffffe76398f3
Autor:
Christoph Schwepcke, Lara Kristina Klauer, Diana Deen, Daniel Christoph Amberger, Zuzana Fischer, Fatemeh Doraneh-Gard, Carina Gunsilius, Annika Hirn-Lopez, Tanja Kroell, Johanna Tischer, Melanie Weinmann, Jan-Ole Werner, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 15; Pages: 8333
Dendritic cells (DC) and leukaemia derived DC (DCleu) are potent stimulators of anti-leukaemic activity in acute myeloid leukaemia (AML) and can be generated from mononuclear cells in vitro following standard DC/DCleu-generating protocols. With respe
Autor:
Jan-Ole Werner, Jennifer Lynn Schiefer, Wiebke Petersen, Manuel Held, Hans-Eberhard Schaller, Afshin Rahmanian-Schwarz, Rebekka Rath
Publikováno v:
Advances in Skin & Wound Care. 32:329-332
Objective To evaluate the effect of a new biologic gelatin-collagen nonwoven scaffold compared with a more common synthetic wound dressing on the healing of superficial wounds. Methods Three superficial wounds with a depth of 0.5 mm and a length of 2
Autor:
Caroline Plett, Lara Kristina Klauer, Daniel Christoph Amberger, Selda Ugur, Alexander Rabe, Zuzana Fischer, Diana Deen, Annika Hirn-Lopez, Carina Gunsilius, Jan-Ole Werner, Jörg Schmohl, Doris Krämer, Andreas Rank, Christoph Schmid, Helga Maria Schmetzer
Publikováno v:
Clinical Immunology. 242:109083
(Leukaemia derived) dendritic cells (DC, DC
Autor:
Gunnar Hübner, Jens Rothenberger, Manuel Held, Hans-Eberhard Schaller, Jan-Ole Werner, Jennifer Lynn Schiefer, Wiebke Petersen, Afshin Rahmanian-Schwarz
Publikováno v:
Burns. 42:1257-1264
Chronic and complex full-thickness wounds have become increasingly prevalent. Besides autologous skin transplantation, innovative wound dressing products have gained interest, as the functional and esthetic outcome is still limited. In this respect,
Autor:
Rebekka Rath, Shahab Rahmanian, Jan-Ole Werner, Hans-Eberhard Schaller, Manuel Held, Jennifer Lynn Schiefer, Wiebke Petersen, Afshin Rahmanian-Schwarz
Publikováno v:
Dermatologic Surgery. 42:751-756
Today, autologous skin transplantation is frequently used for full-thickness skin defects. There is still a high demand for new wound-healing products to replace autologous skin transplantation.In this context, the effect of a new collagen-gelatin sc
Autor:
Rebekka Rath, Manuel Held, Hans-Eberhard Schaller, Jan-Ole Werner, Jennifer Lynn Schiefer, Wiebke Petersen, Afshin Rahmanian-Schwarz
Publikováno v:
Advances in Skin & Wound Care. 29:73-78
OBJECTIVE: Mortality after chronic wounds is high. Thus, proper and effective therapy is of critical importance. Adult mammalian skin cannot regenerate spontaneously. It heals under scar formation in a process of repair. In general, wound closure is
Autor:
Jan Ole Werner, Marius Horger, Mustafa Kurucay, Hans Bösmüller, Joerg Henes, S. D. Ioanoviciu
Publikováno v:
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 189:190-192
Autor:
Mustafa, Kurucay, Jan Ole, Werner, Hans, Bösmüller, Sorin Dumitru, Ioanoviciu, Joerg, Henes, Marius, Horger
Publikováno v:
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 189(3)
Autor:
Heiko Schuster, Daniel J. Kowalewski, Annika Nelde, Helmut R. Salih, Linus Backert, Hans-Georg Rammensee, Reinhild Klein, Stefan Stevanovic, Juliane S. Walz, Oliver Kohlbacher, Lothar Kanz, Jan-Ole Werner
Publikováno v:
OncoImmunology, Vol 7, Iss 4 (2018)
Recent studies suggest that CLL is an immunogenic disease, which might be effectively targeted by antigen-specific T-cell-based immunotherapy. However, CLL is associated with a profound immune defect, which might represent a critical limitation for m